Informa (LON:INF) was upgraded by Peel Hunt to an “add” rating in a research note issued on Friday, May 4th. The firm currently has a GBX 740 ($10.04) target price on the stock. Peel Hunt’s price objective suggests a potential downside of 3.37% from the company’s current price.
INF has been the subject of a number of other reports. Goldman Sachs reaffirmed a “conviction-buy” rating and issued a GBX 846 ($11.48) price objective on shares of Informa in a research note on Monday, March 26th. Liberum Capital reissued a “buy” rating and set a GBX 855 ($11.60) target price on shares of Informa in a research note on Wednesday, February 28th. Deutsche Bank reissued a “buy” rating on shares of Informa in a research note on Friday, April 6th. Numis Securities reissued an “add” rating and set a GBX 825 ($11.19) target price on shares of Informa in a research note on Wednesday, February 28th. Finally, Societe Generale reaffirmed a “buy” rating and set a GBX 810 ($10.99) price target on shares of Informa in a report on Friday, January 26th. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of GBX 806.71 ($10.94).
Shares of Informa traded up GBX 1.60 ($0.02), reaching GBX 765.80 ($10.39), during trading on Friday, according to Marketbeat.com. The stock had a trading volume of 2,379,175 shares, compared to its average volume of 3,640,000. Informa has a fifty-two week low of GBX 624.50 ($8.47) and a fifty-two week high of GBX 773 ($10.49).
Informa Company Profile
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.